BACKGROUND Patients with chronic, immune-mediated conditions such as inflammatory
bowel disease (IBD) are often treated with long-term immunosuppressive therapies, …

OBJECTIVES: The treatment of inflammatory bowel disease (IBD) often includes
immunosuppressive medications, which may increase the risk of vaccine-preventable illnesses. We …

Background: The effects of immunosuppression on responses to SARS-CoV-2 vaccine are
unclear given that patients receiving immune-modifying therapies, who constitute 2.8% of …

Ulcerative colitis is a chronic, relapsing inflammatory condition of the gastrointestinal tract
with a complex genetic and environmental etiology. In an effort to identify genetic variation …

Background The COVID-19 pandemic has claimed the lives of nearly 2 million people
worldwide. 1 Following rapid sequencing of SARS-CoV-2, pharmaceutical companies and …

… Farraye; wrote sections on vaccination, reviewed and edited final manuscript: Gil Y.
Melmed, MD, MS; wrote sections on vaccination, reviewed and edited final manuscript: Gary R. …

… Conflicts of interest These authors disclose the following: Gil Y. Melmed has consulted for
AbbVie, Boehringer-Ingelheim, Janssen, Pfizer, Samsung Bioepis, and Takeda, and has …

… Gil Y. Melmed: data collection, data interpretation, and drafting of manuscript. Carol Landers:
data analysis and drafting of manuscript. Dalin Li: data analysis and drafting of manuscript. …

Introduction Variation in adherence to management guidelines for inflammatory bowel
disease (IBD) suggests variable quality of care. Quality indicators (QIs) can be developed to …

Background & Aims There is controversy regarding the best treatment for patients with
Crohn’s disease because of the lack of direct comparative trials. We compared therapies for …